2^nd World Congress on Antibiotics scheduled in London, UK during October 16-17, 2019 with the theme Improving World Health with Antibiotics. Antibiotics 2019 conference is organized to unite scientists, researchers, teachers, business delegates, students and research associates to communicate about their experience, knowledge and also about the on-going research. Antibiotics 2019 conference focuses on a wide array of sessions which are of scientific interest and also need of the hour which incorporate: Antibiotics – General and meticulously, Pharmacology of Antibiotics, Antibiotics for Emerging & Re-Emerging Diseases, Microorganisms in Recent Drug discovery, Over the Counter Antibiotics, Alternative to Antibiotics, Genetics of Antimicrobial Resistance, Antibiotic Shortage: A Serious Safety Concern, Generic Antibiotics, Veterinary Antibiotics. Antibiotics 2019 conference gathering incorporates Plenary lectures, keynote lectures by eminent personalities from around the world in addition to poster presentation, young researcher sessions, symposiums, workshop, and Exhibitors. Antibiotics 2019 conference is confident that it will definitely offer all participants an unforgettable experience in exploring new opportunities. London is the capital and most populous city of England and the United Kingdom. Standing on the River Thames in the south east of the island of Great Britain, London has been a major settlement for two millennia. We hope you will join us in London, UK.

Target Audience:

Pharmaceutical /Medicine Students,
Life Science scientists
Pharmaceutical Researchers
Pharmacy Faculty
Pharmacology Universities
Business Entrepreneurs
Training Institutes
Pharmaceutics Manufacturing Companies
R&D Laboratories

Session 1 - Antibiotics: General and Meticulously

Antibiotics are powerful medicines that fight bacterial infections. Used properly, antibiotics can save lives. They either kill bacteria or keep them from reproducing. When harmful bacteria are excessive our immune system cannot fight them all and Antibiotics are useful in this scenario. The session is open to discuss on discovery of antibiotics, mechanism, types of antibiotics, usage of drugs, side effects and the serious issues of overdose, interaction with other drugs, allergic reactions caused by the use of antibiotics, applications of antibiotics.

Related Conferences:

20^th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, March 18-20, 2019 Edinburgh, Scotland; 21^st Annual European Pharma Congress, May 20-21, 2019 Zurich, Switzerland; 22^nd International Conference and Exhibition on Pharmaceutical Formulations, June 03-04, 2019 London, UK; 14^th International Conference on Pharmacology and Toxicology, July 18-19, 2019 Zurich, Switzerland.

Session 2 - Pharmacology of Antibiotics

Antibiotics form part of a wider range of antimicrobial agents, a group which also includes antifungals, antivirals, antiprotozoal and disinfectants. This group is also known as chemotherapeutic agents. The session is open for clinical pharmacology of antibiotics, Drug therapy, pathophysiology, pharmacokinetics and pharmacodynamics, drug screening, characterization, synthesis and assays for therapeutic efficacy, drug disposition, regulations needed for the approval of antibiotics, requirements for production of antibiotics, clinical trials, structure – activity relationship, antibiotic prophylaxis.

Related Conferences:

Session 3 - Antibiotics for Emerging & Re-Emerging Diseases

Antibiotic-resistant strains of pathogenic bacteria are increasingly prevalent in hospitals and the community. New antibiotics are needed to combat these bacterial pathogens, but progress in developing them has been slow. The session is open to discuss on synthetic tailoring, discovery of new scaffolds, designing screens that avoid rediscovering old scaffolds, repurposing libraries of synthetic molecules for use as antibiotics, exploring microbial niches for products, molecular target selection, improving libraries to overcome resistance, safety and efficacy, vaccines available for the diseases.

Related Conferences:

Session 4 - Microorganisms in Recent Drug discovery

The sequencing of the first complete bacterial genome in 1995 heralded a new era of hope for antibacterial drug discoverers, who now had the tools to search entire genomes for new antibacterial targets. The session is open to genomics approach to antibacterial discovery, target-based approach, screening for new classes of drugs with novel modes of action, optimization of novel chemical structures and development of novel non antimicrobial-based methods.

Related Conferences:

Session 5 - Over the Counter Antibiotics

Antibiotics come under Schedule H. This is a class of prescription drugs appearing as an appendix to the Drugs and Cosmetics Rules, 1945 introduced in 1945. These are drugs which cannot be purchased over the counter without the prescription of a qualified doctor. The manufacture and sale of all drugs are covered under the Drugs and Cosmetics Act and Rules. It is revised at times based on the advice of the Drugs Technical Advisory Board, part of the Central Drugs Standard Control Organization in the Ministry of Health and Family Welfare. OTC sales make them easily available, which otherwise means their irrational use. This paves way for rapid emergence of resistant strains of dangerous bacteria with serious implications for the future of our society.

Related Conferences:

Session 6 - Alternative to Antibiotics

The antibiotic resistance problem is caused by the evolution and transfer of genes that confer resistance to medically important antibiotics into human pathogens. The acquisition of such resistance genes by pathogens complicates disease treatment, increases health care costs, and increases morbidity and mortality in humans and animals. As antibiotic resistance continues to evolve, antibiotics of so-called last resort become even more precious. Reducing or preventing the dissemination of antibiotic resistance genes into human pathogens is currently of high international importance. The session is open to Antibiotic prudency, bacteriophage therapy, predatory bacteria, bacteriocins, and competitive exclusion of pathogens, Immunotherapeutics, antibodies, vaccines and gut microbiota modulation.

Related Conferences:

Session 7 - Genetics of Antimicrobial Resistance

Acquired bacterial antibiotic resistance can result from the mutation of normal cellular genes, the acquisition of foreign resistance genes, or a combination of these two mechanisms. The session is open for most common resistance mechanisms employed by bacteria, alteration of the antimicrobial, performing / introducing mutation in the antimicrobial target site, active efflux of the antimicrobial across the cell membrane, types of antibiotic resistance, about horizontal gene transfer, molecular genetic work.

Related Conferences:

Session 8 - Antibiotic Shortage: A Serious Safety Concern

Antibiotic shortage is of great concern to FDA and healthcare community as many of the antibiotics were the sole drugs to treat certain antibiotic-resistant infections for certain infectious conditions. Drug shortages pose a serious challenge for health care institutions, often interfering with patient care. A common practice during a drug shortage is to select an alternate therapeutic. However, these agents often present challenges and may create safety concerns. Patient harms including adverse events and medication errors may occur. Patients may also file complaints because of drug shortages. The session is open to discuss on manufacturing site problems, shortage of raw materials, low commercial incentives, lack of approved manufacturers, defect in packaging and labelling.

Related Conferences:

Session 9 - Generic Antibiotics

Generic drugs reduce drug expenses and thereby national medical expenditure. Because generic drugs provide advantages for both public administration and consumers, it is expected that they will be more widely used in the future. The session is open to drug components, levels of impurity, pharmacokinetics, pharmacokinetic/pharmacodynamics relationship, In vitro effectiveness, therapeutic effectiveness in experimental models, marketing authorization of generic antibiotic drugs.

Related Conferences:

Session 10 - Veterinary Antibiotics

Antibiotic drugs are commonly used in veterinary medicine to treat infectious diseases that are caused by bacteria and certain other microorganisms. There are many different classes of antibiotics available for use in animals where some are effective against a wide range of organisms, while others are more closely targeted. When given a prescription from your veterinarian for your pet, make sure that it is given exactly as instructed and that the entire prescription is given. Not following dosage schedules or not giving all of the prescription can cause a relapse, a reinfection, or development of antibiotic-resistant organisms. The session is open to using specific and appropriate supportive treatment to improve the animal’s ability to overcome the infection and associated disease conditions.

Related Conferences:

Introduction:

Antibiotics are the ‘wonder drugs’ to combat microbes. For decades, multiple varieties of antibiotics have not only been used for therapeutic purposes but practiced prophylactically across other industries such as agriculture and animal husbandry. Uncertainty has arisen, as microbes have become resistant to common antibiotics while the host remains unaware that antibiotic resistance has emerged. Antibiotic-resistant infections correlate with the level of antibiotic consumption. Non-judicial use of antibiotics is mostly responsible for making the microbes resistant. The antibiotic treatment repertoire for existing or emerging hard-to-treat multidrug-resistant bacterial infections is limited, resulting in high morbidity and mortality report.

Scope:

Millions of metric tons of newer classes of antibiotics have been produced in last 60 years since its inception. Increased demand for antibiotics across many sectors has allowed for less expensive and off-label uses of drugs. Conversely, due to the enormous and irresponsible use of the antibiotics, has contributed significantly to the advent of the resistant strains. Production of new antibiotics was directly proportional to the development of resistant strains. However, the mainstream approach in fighting against the diseases is now focused on the modification of existing antibiotics to combat emerging and re-emerging resistance of pathogens globally. Resistance to an antibiotic develops in no time and hence, is a big matter of concern. In the developing world, almost all the antibiotics are available over the counter and can be bought without any medical prescription which is one of the most important factors in causing the resistance. Therefore, if the resistance to the antibiotics needs to be curbed, the only way shall be to educate the patients and the general public.

Global Business:

Certain factors which drive market growth include Emergence of anti-MRSA drugs, Development of generic drugs, and vulnerable aging population. As per the current statistics, there are several dominant players and those with innovative thoughts and advancement of techniques, skills hold a significant market share for antibiotics. Almost 80% of the prescription antibiotics are generics which help many people to afford as there is decline in price thus improving the health of an individual. However, indiscriminate drug usage also leads to drug resistance and other complications which are not easy to solve. There is a wide scope for combinational formulations as drug resistance is increasing and discovery of lead molecules is at a slow pace. Global Antibiotics market was valued at USD 42653.89 million in 2018 and is estimated to be valued at USD 56369.92 million in 2024, witnessing a CAGR of 4.7%.

Future Scope:

The ways we have developed, used and protected antibiotics have led predictably to our current crisis of rising antibiotic resistance and declining new treatments. If we want to stave off a post antibiotic era, we need to fundamentally change our approach. Ultimately, there is need for a coordinated national action plan to combat resistance.

Conclusion:

Antibiotic resistance is at all-time high in all the parts of the world. Despite measures taken by some member states of WHO, antibiotic use in humans, animals, and agriculture is increasing. The high economic burden in the healthcare sector has become a burning issue, due to extended hospital stays, isolation wards, stringent infection control measures and treatment failures. The public health leaders should establish a pan surveillance system coordinated at national and international levels, on-going analysis and a mandatory reporting system for antibiotic resistance. Both domestic and global policies need to be conventional and adhered-to to stop the overuse and misuse of antibiotics.

Global Universities in USA:

University of Southern California

CUNY York College

Purdue University

University of Wisconsin-Madison

Albany College of Pharmacy and Health Sciences

University of North Carolina

University of Colorado

Oregon State University

Massachusetts College of Pharmacy and Health Sciences

University of Florida College of Pharmacy

Global Universities in Europe:

University of Oxford

University of Cambridge

University College London

University of Edinburgh

Imperial College London

University of Manchester

Catholic University of Leuven

University of Amsterdam

King's College London

University of Copenhagen

Global Universities in Asia:

University of Tokyo

National University of Singapore

Kyoto University

University of Hong Kong | Peking University

Seoul National University

National Taiwan University

Osaka University

Tsinghua University

Chinese University of Hong Kong

The Hong Kong University of Science and Technology

References:

www.mordorintelligence.com/industry-reports/antibiotics-market

www.ncbi.nlm.nih.gov/pmc/articles/PMC5573035/

www.ncbi.nlm.nih.gov/pmc/articles/PMC4176319/

About Us

Recommended Conferences

2^nd International Conference on Nutraceuticals

12^th International Conference on Pharmaceutical Chemistry

11^th World Conference on Biosimilars and Biologics

14th International Conference on Pharmacology and Toxicology

15th World Congress On Bioavailability & Bioequivalence

Co-located Event

Wound Care 2019

What We Offer?

Meet Experts

Global Networking

Learning In a New Space

New Tips & Tactics

Certification

About Us

Recommended Conferences

2nd International Conference on Nutraceuticals

12th International Conference on Pharmaceutical Chemistry

11th World Conference on Biosimilars and Biologics

14th International Conference on Pharmacology and Toxicology

15th World Congress On Bioavailability & Bioequivalence

Co-located Event

Wound Care 2019

What We Offer?

Meet Experts

Global Networking

Learning In a New Space

New Tips & Tactics

Certification

2^nd International Conference on Nutraceuticals

12^th International Conference on Pharmaceutical Chemistry

11^th World Conference on Biosimilars and Biologics